血栓形成与血小板：最新进展
Thrombosis and platelets: an update.
作者信息
Koupenova Milka, Kehrel Beate E, Corkrey Heather A, Freedman Jane E
机构信息
University of Massachusetts Medical School, Albert Sherman Center, 368 Plantation St, Worcester, MA 01605, USA.
Westfälische Wilhelms University Muenster, Münster, University Hospital, Department of Anaesthesiology, Intensive Care and Pain Medicine, Experimental and Clinical Haemostasis Research, D-48149 Muenster, Germany Mendelstrasse 11, UK.
出版信息
Eur Heart J. 2017 Mar 14;38(11):785-791. doi: 10.1093/eurheartj/ehw550.
Abstract
Haemostasis and thrombosis are complex, multifactorial processes. There is an evolving understanding of the mechanisms influencing vascular occlusion and the role of inflammation and immunity. Despite major advances in elucidating the mechanistic pathways mediating platelet function and thrombosis, challenges in the treatment of vascular occlusive diseases persist. Pharmacological advances have greatly affected thrombotic outcomes, but this has led to the unwanted side effect of bleeding. Detailed assessment of the impact of non-thrombotic diseases on haemostasis and thrombosis is necessary to better evaluate thrombotic risk and establish optimal treatment. This review will focus on recent advances in understanding the contribution of evolving risk factors to thrombosis.
摘要
止血和血栓形成是复杂的多因素过程。人们对影响血管闭塞的机制以及炎症和免疫的作用的认识正在不断发展。尽管在阐明介导血小板功能和血栓形成的机制途径方面取得了重大进展，但血管闭塞性疾病的治疗挑战依然存在。药理学进展极大地影响了血栓形成的结果，但这也导致了出血这一不良副作用。详细评估非血栓性疾病对止血和血栓形成的影响对于更好地评估血栓形成风险和确立最佳治疗方法很有必要。本综述将聚焦于在理解不断变化的风险因素对血栓形成的影响方面的最新进展。
相似文献
1
Thrombosis and platelets: an update.血栓形成与血小板：最新进展
Eur Heart J. 2017 Mar 14;38(11):785-791. doi: 10.1093/eurheartj/ehw550.
2
Circulating Platelets as Mediators of Immunity, Inflammation, and Thrombosis.循环血小板作为免疫、炎症和血栓形成的介质。
Circ Res. 2018 Jan 19;122(2):337-351. doi: 10.1161/CIRCRESAHA.117.310795.
3
[Hemostasis and blood coagulation revisited: mechanisms and therapeutic implications].[再探止血与血液凝固：机制及治疗意义]
J Pharm Belg. 2004;59(1):15-26.
4
High-density lipoprotein as a modulator of platelet and coagulation responses.高密度脂蛋白作为血小板和凝血反应的调节剂。
Cardiovasc Res. 2014 Aug 1;103(3):362-71. doi: 10.1093/cvr/cvu137. Epub 2014 Jun 1.
5
The pivotal role of the endothelium in haemostasis and thrombosis.内皮细胞在止血和血栓形成中的关键作用。
Acta Clin Belg. 2006 Sep-Oct;61(5):213-9. doi: 10.1179/acb.2006.036.
6
[The role of platelets in haemostasis, thrombosis, immune defense and inflammation].[血小板在止血、血栓形成、免疫防御和炎症中的作用]
Dtsch Med Wochenschr. 2008 May;133(21):1130-5. doi: 10.1055/s-2008-1077228.
7
Platelets and Their Role in Hemostasis and Thrombosis-From Physiology to Pathophysiology and Therapeutic Implications.血小板及其在止血和血栓形成中的作用——从生理学到病理生理学及治疗意义。
Int J Mol Sci. 2022 Oct 23;23(21):12772. doi: 10.3390/ijms232112772.
8
Pathophysiology of Thrombosis in Peripheral Artery Disease.外周动脉疾病中的血栓形成的病理生理学。
Curr Vasc Pharmacol. 2020;18(3):204-214. doi: 10.2174/1570161117666190206234046.
9
Platelet activation by extracellular matrix proteins in haemostasis and thrombosis.细胞外基质蛋白在止血和血栓形成过程中对血小板的激活作用。
Curr Pharm Des. 2009;15(12):1358-72. doi: 10.2174/138161209787846702.
10
Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms.血小板在慢性骨髓增殖性肿瘤中的血栓炎症中介作用。
Front Immunol. 2019 Jun 14;10:1373. doi: 10.3389/fimmu.2019.01373. eCollection 2019.
引用本文的文献
1
Genetic Architecture of Ischemic Stroke: Insights from Genome-Wide Association Studies and Beyond.缺血性中风的遗传结构：全基因组关联研究及其他方面的见解
J Cardiovasc Dev Dis. 2025 Jul 23;12(8):281. doi: 10.3390/jcdd12080281.
2
(Cys228Tyr) missense mutation associated with mesenteric and pulmonary venous thromboembolism during the COVID-19 pandemic: a case report.与新冠疫情期间肠系膜和肺静脉血栓栓塞相关的（Cys228Tyr）错义突变：一例报告
Front Cardiovasc Med. 2025 Jul 23;12:1610580. doi: 10.3389/fcvm.2025.1610580. eCollection 2025.
3
Potential Compounds as Inhibitors of Staphylococcal Virulence Factors Involved in the Development of Thrombosis.作为葡萄球菌毒力因子抑制剂的潜在化合物，这些毒力因子参与血栓形成过程。
Toxins (Basel). 2025 Jul 4;17(7):340. doi: 10.3390/toxins17070340.
4
Platelets in infection: intrinsic roles and functional outcomes.感染中的血小板：内在作用与功能结果
Front Immunol. 2025 Jul 7;16:1616783. doi: 10.3389/fimmu.2025.1616783. eCollection 2025.
5
A programmable platelet theranostic platform for adaptive multi-stage delivery and synergistic immunotherapy in atherosclerosis.一种用于动脉粥样硬化中适应性多阶段递送和协同免疫治疗的可编程血小板诊疗平台。
Nat Commun. 2025 Jul 11;16(1):6445. doi: 10.1038/s41467-025-61789-9.
6
Contrast transthoracic echocardiography in a patient with drug-induced hypersensitivity syndrome with right atrial thrombus: A case report and mini review.药物性超敏反应综合征合并右心房血栓患者的对比剂经胸超声心动图检查：病例报告及简要综述
Pediatr Discov. 2024 Apr 23;2(2):e52. doi: 10.1002/pdi3.52. eCollection 2024 Jun.
7
Thromboinflammation vs. immunothrombosis: strategies for overcoming anticoagulant resistance in COVID-19 and other hyperinflammatory diseases. Is ROTEM helpful or not?血栓炎症与免疫血栓形成：克服COVID-19和其他高炎症性疾病中抗凝抵抗的策略。旋转血栓弹力图（ROTEM）是否有用？
Front Immunol. 2025 Jun 19;16:1599639. doi: 10.3389/fimmu.2025.1599639. eCollection 2025.
8
Surface-Anchored Ticagrelor Gelatin Nanoparticles-Platelets System for Enhanced Anti-PD-L1 Therapy Response and Boosted Chemotherapeutic Efficacy of Nanomedicines.用于增强抗PD-L1治疗反应和提高纳米药物化疗疗效的表面锚定替格瑞洛明胶纳米颗粒-血小板系统
Exploration (Beijing). 2025 Mar 6;5(3):20240084. doi: 10.1002/EXP.20240084. eCollection 2025 Jun.
9
The triglyceride-glucose index positively associates with the prevalence and severity of coronary heart disease in patients among hypertension.甘油三酯-葡萄糖指数与高血压患者冠心病的患病率及严重程度呈正相关。
Sci Rep. 2025 Jun 4;15(1):19571. doi: 10.1038/s41598-025-03948-y.
10
Friend or foe: the role of platelets in acute lung injury.敌友之间：血小板在急性肺损伤中的作用
Front Immunol. 2025 May 14;16:1556923. doi: 10.3389/fimmu.2025.1556923. eCollection 2025.
本文引用的文献
1
Pregnancy loss and risk of ischaemic stroke and myocardial infarction.妊娠丢失与缺血性卒中和心肌梗死风险。
Br J Haematol. 2016 Jul;174(2):302-9. doi: 10.1111/bjh.14043. Epub 2016 Apr 7.
2
Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsø Study.事件性心肌梗死对静脉血栓栓塞风险的影响：特罗姆瑟研究。
J Thromb Haemost. 2016 Jun;14(6):1183-91. doi: 10.1111/jth.13329. Epub 2016 May 10.
3
Subsequent arterial ischemic events in patients receiving anticoagulant therapy for venous thromboembolism.接受静脉血栓栓塞抗凝治疗的患者随后发生的动脉缺血事件。
J Vasc Surg Venous Lymphat Disord. 2015 Apr;3(2):135-41.e1. doi: 10.1016/j.jvsv.2014.11.002. Epub 2015 Mar 13.
4
Factors associated with thrombosis in pediatric patients with systemic lupus erythematosus.儿童系统性红斑狼疮患者血栓形成的相关因素
Lupus. 2016 Jun;25(7):749-53. doi: 10.1177/0961203316638164. Epub 2016 Mar 14.
5
Risk of Cerebral Venous Thrombosis in Obese Women.肥胖女性发生脑静脉血栓的风险。
JAMA Neurol. 2016 May 1;73(5):579-84. doi: 10.1001/jamaneurol.2016.0001.
6
Venous and Arterial Thrombotic Events in Systemic Lupus Erythematosus.系统性红斑狼疮中的静脉和动脉血栓形成事件
J Rheumatol. 2016 Mar;43(3):576-86. doi: 10.3899/jrheum.150506. Epub 2016 Jan 15.
7
Microvesicle Tissue Factor Activity and Interleukin-8 Levels are Associated with Mortality in Patients with Influenza A/H1N1 Infection.微泡组织因子活性和白细胞介素-8水平与甲型H1N1流感感染患者的死亡率相关。
Crit Care Med. 2016 Jul;44(7):e574-8. doi: 10.1097/CCM.0000000000001584.
8
Association of Serum Sex Hormones with Hemostatic Factors in Women On and Off Hormone Therapy: The Multiethnic Study of Atherosclerosis.接受和未接受激素治疗的女性血清性激素与止血因子的关联：动脉粥样硬化的多民族研究
J Womens Health (Larchmt). 2016 Feb;25(2):166-72. doi: 10.1089/jwh.2015.5465. Epub 2015 Dec 24.
9
Interaction of Hereditary Thrombophilia and Traditional Cardiovascular Risk Factors on the Risk of Arterial Thromboembolism: Pooled Analysis of Four Family Cohort Studies.遗传性血栓形成倾向与传统心血管危险因素对动脉血栓栓塞风险的相互作用：四项家族队列研究的汇总分析
Circ Cardiovasc Genet. 2016 Feb;9(1):79-85. doi: 10.1161/CIRCGENETICS.115.001211. Epub 2015 Dec 17.
10
Genetic risk factors in patients with deep venous thrombosis, a retrospective case control study on Iranian population.静脉血栓栓塞症患者的遗传风险因素：伊朗人群的回顾性病例对照研究。
Thromb J. 2015 Nov 10;13:35. doi: 10.1186/s12959-015-0064-y. eCollection 2015.
Zotero 插件